Keep­ing an 'im­mi­grant mind­set,' Flag­ship taps a self-pro­fessed no­mad as CEO for their next-gen vi­ral vec­tor up­start

Tuyen Ong con­sid­ers him­self a bit of a no­mad.

Ear­ly in his life, he came to the UK as a refugee from Viet­nam, and ob­tained his MD at Uni­ver­si­ty Col­lege Lon­don. Then he went to NYU for an MBA and be­gan his ca­reer in bio­phar­ma at Pfiz­er, mak­ing fur­ther stops across the coun­try at Bausch + Lomb, PTC Ther­a­peu­tics and most re­cent­ly Bio­gen.

Now, he’s ready for his next gig: CEO-part­ner at Flag­ship Pi­o­neer­ing and CEO of Ring Ther­a­peu­tics, a gene ther­a­py out­fit where he’ll be run­ning the show. When Ong looks back at his ca­reer, he says he can see how all the dots con­nect­ed to lead him to this point.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER